The Michael J. Fox Foundation and Imago Pharmaceuticals Partner to Speed Parkinson


(May 20, 2015) - The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced the acquisition of a library of research tools around the parkin protein from Imago Pharmaceuticals. The Foundation believes these tools — cell lines, plasmids, compounds and more — will accelerate biological study and drug development against this promising disease-modification target. Read more…

Click for a printer friendly version

Back to top